Kpj Healthcare BhdXKLS:5878 +2.19%76 EBITDA Margin % is 22.90% as of Mar. 2026, which is 3% below its 10-year median of 23.67. GuruFocus rates XKLS:5878 with a GF Score™ of 76/100 and a GF Value™ of RM2.48 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Kpj Healthcare Bhd ranks better than 84.88% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Kpj Healthcare Bhd's EBITDA for the
three
months ended in Mar. 2026 was RM240 Mil. Kpj Healthcare Bhd's Revenue for the
three
months ended in Mar. 2026 was RM1,050 Mil. Therefore, Kpj Healthcare Bhd's EBITDA margin for the quarter that ended in Mar. 2026 was 22.90%.
Kpj Healthcare Bhd (XKLS:5878) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Kpj Healthcare Bhd EBITDA Margin % Related Terms
Kpj Healthcare Bhd EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Kpj Healthcare Bhd's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:5878 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Kpj Healthcare Bhd's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kpj Healthcare Bhd EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Kpj Healthcare Bhd's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Kpj Healthcare Bhd's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kpj Healthcare Bhd (XKLS:5878) has a EBITDA Margin % of 22.90% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Kpj Healthcare Bhd and its competitors. This is near median its historical median of 23.67. Over the past decade, Kpj Healthcare Bhd's EBITDA Margin % has ranged from 14.13 to 25.93. According to the industry distribution chart, Kpj Healthcare Bhd ranks #101 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 15.1%.
Is Kpj Healthcare Bhd's EBITDA Margin % too high?
Kpj Healthcare Bhd's current EBITDA Margin % of 22.90% is near median its 10-year median of 23.67. Over the past 10 years, this metric has ranged from a low of 14.13 to a high of 25.93. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Kpj Healthcare Bhd's value of 22.90% is 124.3% above this industry median. Based on the distribution chart, Kpj Healthcare Bhd ranks #101 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Kpj Healthcare Bhd has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kpj Healthcare Bhd's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Kpj Healthcare Bhd ranks #101 out of 668 companies for EBITDA Margin %. This places Kpj Healthcare Bhd in the top 15% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. Kpj Healthcare Bhd's value of 22.90% is 124.3% above this benchmark. Historically, Kpj Healthcare Bhd's own EBITDA Margin % has ranged from 14.13 to 25.93 over the past decade. While the company's 10-year median is 23.67 vs. the industry median of 10.21, Kpj Healthcare Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kpj Healthcare Bhd's current EBITDA Margin % of 22.90% is 124.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Kpj Healthcare Bhd and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kpj Healthcare Bhd's current EBITDA Margin % is 22.90%, which is near median its own 10-year median of 23.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kpj Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, Kpj Healthcare Bhd (XKLS:5878) is currently considered Significantly Overvalued. The stock's GF Value™ is RM2.48, compared to a current price of RM3.26 — trading 31.5% above its estimated fair value. The current EBITDA Margin % is 22.90%, which is near median its 10-year median of 23.67 and 124.3% above the Healthcare Providers & Services industry median of 10.21. Kpj Healthcare Bhd's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Kpj Healthcare Bhd (XKLS:5878), the current EBITDA Margin % is 22.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kpj Healthcare Bhd (XKLS:5878) Overvalued in 2026?
Based on GuruFocus' analysis, Kpj Healthcare Bhd stock appears to be overvalued.
The current stock price of RM3.26 is trading 31.5% above its estimated GF Value™ of RM2.48.
GuruFocus considers Kpj Healthcare Bhd to be Significantly Overvalued.
Key valuation signals for XKLS:5878:
EBITDA Margin %: 22.90% (near median its 10-year median of 23.67)
GF Value™: RM2.48 vs. price of RM3.26 (31.5% above fair value)
Industry Position: 124.3% above the Healthcare Providers & Services median (#101 of 668)
No single metric tells the full story. See the XKLS:5878 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KPJ Healthcare Bhd operates as an investment holding company and provides management services to its subsidiaries. The principal activities of the subsidiaries are mainly the operation of specialist hospitals. The reportable segments of the company are: (i) Malaysia - All healthcare activities including the private hospitals, pathology and laboratory services and distribution of pharmaceutical, medical and consumer healthcare products. (ii) Others - Operating segments involved in provision of hospital and retirement village services in Thailand and Australia, a private university and colleges of nursing and allied health and other similar activities in Malaysia. The majority of revenue is derived from the Malaysia segment.
76GF Score
Get the complete analysis for XKLS:5878
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5878 has been successfully added to your 
